Showing results (161-170 of 235) with videos related to
Sort By:
Pageof 24
Frontiers in Immunology|May 27, 2022
Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-SeroconvertorsAthina Kilpeläinen, Esther Jimenez-Moyano, Oscar Blanch-Lombarte, et al.Journal of Virology|March 16, 2006
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1Javier Martinez-Picado, Julia G Prado, Elizabeth E Fry, et al.Journal of Virological Methods|May 17, 2006
Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomesChristine M Rousseau, Brian A Birditt, Angela R McKay, et al.Science (New York, N.Y.)|March 17, 2007
Founder effects in the assessment of HIV polymorphisms and HLA allele associationsTanmoy Bhattacharya, Marcus Daniels, David Heckerman, et al.Science Translational Medicine|June 27, 2014
HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humansFelix Bohne, María-Carlota Londoño, Carlos Benítez, et al.Nature|December 3, 2002
HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virusMarcus Altfeld, Todd M Allen, Xu G Yu, et al.Journal of Virology|January 26, 2007
Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopesIsobella Honeyborne, Andrew Prendergast, Florencia Pereyra, et al.Journal of Virology|May 18, 2007
Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infectionHayley Crawford, Julia G Prado, Alasdair Leslie, et al.Vaccines|December 11, 2019
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMixWesley de Jong, Lorna Leal, Jozefien Buyze, et al.European Journal of Immunology|October 16, 2015
Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cellsNicola Ternette, Hongbing Yang, Thomas Partridge, et al.Pageof 24